Antifungal Market Global Analysis and 2016-2020 Forecasts Research Report

Market Research Reports and Industry Analysis
OrbisResearch.com has published “Global Antifungal Market: Industry Analysis and Outlook (2016-2020)” market report to its research database. The US is the largest market of anti-fungal drugs. It covers the regional and global aspects of the market. The key companies profiled in the report are JNJ, Novartis, Pfizer, and Merck & Co.

Fungal infection is most common in those with weakened immune system or those who have foreign material, including medical devices in their body like an artificial joint or heart valve. Fungal infections are categorized under opportunistic and primary fungal infection. Opportunistic fungal infection targets weak immune patients and can be very aggressive, spreading quickly to other organs and often leading to death. While primary fungal infection can occur in people with a normal immune system. There are several types of antifungal medicines. They come in as creams, sprays, solutions, tablets designed to go into the vagina (pessaries), shampoos, medicines to take by mouth, and injections. Most work by damaging the cell wall of the fungus, which causes the fungal cell to die.

Request a sample of this report at http://www.orbisresearch.com/contacts/request-sample/140135 .

The US is the largest market of anti-fungal drugs. It has the presence of the leading companies who specialize in anti-fungal drugs. The key factors driving growth of the anti-fungal market include rise in incidences of fungal infections in immuno-compromised patients, increase in number of cancer patients, rise in incidences of fungal infections in people suffering from AIDS, increase in spending on medicines, rise in sale of prescription drugs and many more.

However, market growth is hindered by the factors such as harsh side effects of drugs, drug resistance, high cost of anti-fungal, and lack of new anti-fungal therapies. The major trends featuring the market include increase in development of new drugs, flourishing public-private partnership in pharmaceutical industry, and growing awareness.

The report offers an in-depth analysis of the “Global Anti-Fungal Market” with special focus on invasive anti-fungal segment. It covers the regional and global aspects of the market. The top notch players in the market exhibit a very close competition. The report profiles JNJ, Novartis, Pfizer, and Merck & Co.

Major Points from Table of Contents:
1. Market Overview
2. Global Antifungal Market
3. Global Invasive Antifungal Market
4. Regional Anti-Fungal Market Analysis
5. Market Dynamics
6. Competitive Landscape
7. Company Profiles

List of Figures:
Types of Fungal Infections
Drugs for Serious Fungal Infections
Global Anti-Fungal Market by Value (2011-2015)
Global Anti-Fungal Market Forecast by Value (2016-2020)
Global Anti-Fungal Market by Region (2015)
Global Invasive Anti-Fungal Market by Value (2011-2015)
Global Invasive Anti-Fungal Market Forecast by Value (2016-2020)
Global Invasive Anti-Fungal Market by Drug Class (2015)
Global Invasive Anti-Fungal Market by Major Drugs (2015)
Global Invasive Anti-Fungal Market by Target Patients (2015)
North America Anti-Fungal Market by Value (2011-2015)
North America Anti-Fungal Market Forecast by Value (2016-2020)
Latin & South America Anti-Fungal Market by Value (2011-2015)
Latin & South America Anti-Fungal Market Forecast by Value (2016-2020)
Latin & South America Anti-Fungal Market Forecast by Value (2016-2020)
Europe Anti-Fungal Market Forecast by Value (2016-2020)
Global New Cancer Patients by Volume (2011-2015)
Increase in Sales of Prescription Drugs (2010-2015)
Global Spending on Medicines (2010-2020E)
Total Spending on Medicines in the US (2010-2015)
Global Healthcare Expenditure (2009-2015)
Increasing Global Ageing Population of 60 Years or Older (2000-2030E)
Revenue Comparison of Key Players (2015)
Market Cap Comparison of Key Players (2015)
Johnson & Johnson Revenue Share by Business Segments (2015)
Johnson & Johnson Revenue and Net Income (2012-2015)
Novartis Revenue Share by Segments (2015)
Novartis Revenue and Net Income (2012-2015)
Pfizer Inc. Revenue Share by Segment (2015)
Pfizer Inc. Revenue and Net Income (2012-2015)
Merck & Co. Inc. Revenue Share by Segments
Merck & Co. Inc. Revenue and Net Income (2011-2015)

Place a direct purchase order on this report at http://www.orbisresearch.com/contact/purchase/140135 .  AND if you have enquire before buying this report visit at http://www.orbisresearch.com/contacts/enquiry-before-buying/140135 .

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Media Contact
Company Name: Orbis Research
Contact Person: Hector Costello
Email: Send Email
Phone: +1 (214) 884-6817
Address:4144N Central Expressway, Suite 600
City: Dallas
State: Texas
Country: United States
Website: http://www.orbisresearch.com/reports/index/global-antifungal-market-industry-analysis-and-outlook-2016-2020